TMCnet News
Research and Markets: Europe Injectable Drug Delivery Market Expected To Reach $207.3 Billion By 2020 From $114.7 Billion In 2015, Growing at a CAGR of 12.6%Research and Markets (http://www.researchandmarkets.com/research/g7nccz/european) has announced the addition of the "European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020" report to their offering. Injectable drug delivery offers a promising alternative for the delivery of drugs that are ineffective when administered orally. Injectable drug delivery is aimed to maximize patient compliance and reduce the frequency of dosage administration without compromising the effectiveness of the treatment. The European injectable drug delivery market is expected to reach $207.3 billion by 2020 from $114.7 billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. The oncology segment is expected to witness the highest CAGR in the forecast period. The major factors responsible for the growth of Europe's injectable drug delvery market are the rising prevalence of chronic diseases, growth of the biologics market, rising demand for self-injection devices, and technological advancements. Owing to these factors, the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes is increasing. On the other hand, alternative methods such as oral and transdermal delivery, safety concerns, and risk of blood-borne infections are expected to restrain the growth of this market. Key Topics Covered
Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/g7nccz/european View source version on businesswire.com: http://www.businesswire.com/news/home/20150820005530/en/ |
